Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome?

Walid Chayoua*, Phillip L. R. Nicolson, Joost C. M. Meijers, Caroline Kardeby, Lourdes Garcia-Quintanilla, Katrien M. J. Devreese, Bas de Laat, Stephen P. Watson, Philip G. de Groot

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1776-1782
Number of pages7
JournalJournal of Thrombosis and Haemostasis
Issue number7
Publication statusPublished - Jul 2021


  • antiphospholipid syndrome
  • antiprothrombin antibodies
  • DOACs
  • thrombosis
  • vitamin K antagonists

Cite this